These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18812474)
41. Overcoming reprogramming resistance of Fanconi anemia cells. Müller LU; Milsom MD; Harris CE; Vyas R; Brumme KM; Parmar K; Moreau LA; Schambach A; Park IH; London WB; Strait K; Schlaeger T; Devine AL; Grassman E; D'Andrea A; Daley GQ; Williams DA Blood; 2012 Jun; 119(23):5449-57. PubMed ID: 22371882 [TBL] [Abstract][Full Text] [Related]
42. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia. Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787 [TBL] [Abstract][Full Text] [Related]
43. Stem cell collection and gene transfer in Fanconi anemia. Kelly PF; Radtke S; von Kalle C; Balcik B; Bohn K; Mueller R; Schuesler T; Haren M; Reeves L; Cancelas JA; Leemhuis T; Harris R; Auerbach AD; Smith FO; Davies SM; Williams DA Mol Ther; 2007 Jan; 15(1):211-9. PubMed ID: 17164793 [TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells. Skvarova Kramarzova K; Osborn MJ; Webber BR; DeFeo AP; McElroy AN; Kim CJ; Tolar J Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28613254 [TBL] [Abstract][Full Text] [Related]
53. In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC. Kurre P; Anandakumar P; Grompe M; Kiem HP Exp Hematol; 2002 Nov; 30(11):1257-62. PubMed ID: 12423678 [TBL] [Abstract][Full Text] [Related]
55. Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia. Oppezzo A; Bourseguin J; Renaud E; Pawlikowska P; Rosselli F J Clin Invest; 2020 Mar; 130(3):1377-1391. PubMed ID: 31877112 [TBL] [Abstract][Full Text] [Related]
56. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. Yamashita T; Nakahata T Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803 [TBL] [Abstract][Full Text] [Related]
57. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells. Du W; Amarachintha S; Wilson AF; Pang Q Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373 [TBL] [Abstract][Full Text] [Related]
58. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298 [TBL] [Abstract][Full Text] [Related]
59. Finding the needle in the hay stack: hematopoietic stem cells in Fanconi anemia. Müller LU; Williams DA Mutat Res; 2009 Jul; 668(1-2):141-9. PubMed ID: 19508850 [TBL] [Abstract][Full Text] [Related]
60. A possible approach for stem cell gene therapy of Fanconi anemia. Song L Curr Gene Ther; 2009 Feb; 9(1):26-32. PubMed ID: 19275569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]